Inactivated Poliovirus Vaccine Closing the Type 2 Immunity Gap in Vietnam

This was a cross-sectional community-based serological survey of polio antibodies assessing the immunogenicity of inactivated poliovirus vaccine (IPV) focusing on poliovirus serotype 2. IPV was administered to 5-month-old children. Type 2 antibody seroprevalence when measured 1 month after IPV admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huyen, Dang Thi Thanh, Anh, Dang Duc, Trung, Nguyen Thanh, Hong, Duong Thi, Thanh, Tran Trung, Truong, Luong Ngoc, Jeyaseelan, Visalakshi, Lopez Cavestany, Rocio, Hendley, William S, Mainou, Bernardo A, Mach, Ondrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520283/
https://www.ncbi.nlm.nih.gov/pubmed/35801634
http://dx.doi.org/10.1093/jpids/piac046
Descripción
Sumario:This was a cross-sectional community-based serological survey of polio antibodies assessing the immunogenicity of inactivated poliovirus vaccine (IPV) focusing on poliovirus serotype 2. IPV was administered to 5-month-old children. Type 2 antibody seroprevalence when measured 1 month after IPV administration was >95%. One IPV dose successfully closed the immunity gap.

Ejemplares similares